Introduction
Proper treatment of penile prosthesis infection almost always requires complete device removal: 1 hence, these infections are the bane of penile prosthetic surgery. What is the likelihood of infection in a man who is about to undergo prosthesis implantation? Is there increased probability of infection if the recipient has had previous penile prosthetic surgery? Is there an increased likelihood of infection if he is a diabetic? We performed a retrospective review of a large series of penile prosthesis implants in an attempt to answer these questions.
Materials and methods
Patients with periprosthetic infection following penile prosthesis implantation were identified by reviewing computer registry records of patients implanted with three-piece inflatable penile prostheses from April 1986 to March 1999. Excluded from this review were the second implants in patients who had salvage procedures for infected prostheses. 2 All patients were free of urinary tract infection and dermatitis or infected skin lesions in the operative area at the time of device implantation. All patients were given gentamicin and vancomycin 1 h before the skin incision was made. A transverse upper scrotal or mid line penoscrotal approach was used in all cases. Bacteriological culture report data were obtained by a review of the medical records. Statistical significance was determined by Fisher's exact test.
Results
There were 491 three-piece inflatable penile prosthesis recipients (267 AMS 700CX or CXM and 224 AMS Ultrex) with follow-up ranging from 1 to 168 months (mean 83). All patients had device implantation more than 1 y ago. Infections are shown in Table 1 . Device removal (explant) was performed in each case once it was apparent that infection was present. Explants for infection were performed in 8 weeks or less following implantation in eight patients. In two patients explants occurred at 17 and 26 months following implantation. Organisms cultured from the periprosthetic space are shown in Table 2 .
Discussion
In early series infection rates after penile prosthesis implantation ranged from 0.6 to 16.7% for nonhydraulic devices, from 3.0 to 8.1% for one-piece hydraulic devices, and from 0.8 to 8% for threepiece hydraulic devices. 3 In series reported more recently, however, the infection rates for first time (primary) penile prosthesis implantations are quite similar. In four separate studies the number of primary implants and the infection rates (%) were as follows: 823 (1.0%), 4 360 (1.7%), 5 269 (1.9%) 6 and 114 (1.8%). 7 Our overall rate of infection (10 cases in 491 implants, 2.0%), compares favorably with the above results.
Infection rates following revisions or repeat implant procedures have traditionally been significantly higher than those following primary (first time) implants. In the same study that reported a 1% infection rate in 823 primary penile prosthesis implant procedures, the rate of infection following 428 revisions was 10%. 4 The study reporting a 1.8% infection rate in 114 primary implants also reported a 13.3% infection rate in 30 revisions. However in our series the 1.5% infection rate in 206 secondary procedures was not statistically different from the 2.5% infection rate in 285 primary procedures.
In the early days of inflatable prosthetic surgery when mechanical failures were common and often occurred within a short time following device implantation, revisions usually entailed replacement of only the component that had failed. Today because mechanical failures are less frequent and usually occur many years following device implantation, management of these failures is more often accomplished by complete device removal, copious antibiotic irrigation of all component spaces, and implantation of a new device. All of the secondary procedures in our series consisted of mechanical failures or otherwise unsatisfactory implants managed in this manner (97 cases) or repeat prosthesis implantation following previous removal of a failed or infected prosthesis (109 cases). 8 Factors such as pseudocapsule formation around prosthetic material, 9, 10 and bacterial adherence to the prosthesis in a biofilm, 11, 12 may explain the higher infection rates reported in earlier revision procedures when old prosthetic material was retained.
Eight of our 10 infections resulted in device removal in 8 weeks or less following implantation. Two infections resulted in device removal later at 17 and 26 months. Neither of the two late infections had other foci of infection that might have resulted in hematogenous spread to the prosthesis, 1, 13 therefore it remains uncertain why these two infections presented late.
Staph. epidermidis was earlier believed to be responsible for more than 50% of genitourinary (GU) prosthetic infections, 4,14,15 however, not all series report infections with this organism, 6 and more recently it has been suggested that Staph. epidermidis may be a contaminant, at least in some cases. 16 In none of the current infections was Staph. epidermidis found in the cultures of the periprosthetic space.
Do diabetic penile prosthesis recipients have a higher rate of infection? Bishop et al found that diabetics with a glycosylated hemoglobin level greater than 11.5 % had an increased likelihood of penile prosthesis infection; 17 however, Wilson et al found no relationship between glycosylated hemoglobin levels in diabetics and penile prosthesis infection. 18 We did not have data concerning glycosylated hemoglobin levels in many of our diabetic patients; however, there was no significant difference in infection rates between non-diabetic and diabetic patients in our series. This confirms our earlier findings, 15 and it also confirms the findings of others. 4, 5 
Conclusions
We found an infection rate of 2.0% in 491 threepiece inflatable penile prosthesis recipients which is similar to rates found in several other series. Unlike others, however, we did not find an increased rate of infection in secondary implants compared to primary implants. Like others we have not found an increased risk of infection in diabetic men. 
